Rational design of solid lipid-polymer hybrid nanoparticles: An innovative glycoalkaloids-carrier with potential for topical melanoma treatment.

Autor: Gonçalves YG; GNanoBio, School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, Ribeirão Preto, SP, Brazil., Kravicz M; School of Surgery and Medicine, University of Milano-Bicocca, Italy., Massaro TNC; GNanoBio, School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, Ribeirão Preto, SP, Brazil., Aldana-Mejía JA; School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, Ribeirão Preto, SP, Brazil., Bastos JK; School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, Ribeirão Preto, SP, Brazil., L Bentley MVB; School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, Ribeirão Preto, SP, Brazil., Marcato PD; GNanoBio, School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, Ribeirão Preto, SP, Brazil. Electronic address: pmarcato@fcfrp.usp.br.
Jazyk: angličtina
Zdroj: Colloids and surfaces. B, Biointerfaces [Colloids Surf B Biointerfaces] 2024 Oct; Vol. 242, pp. 114098. Date of Electronic Publication: 2024 Jul 16.
DOI: 10.1016/j.colsurfb.2024.114098
Abstrakt: Despite the promising potential of Solanum plant glycoalkaloids in combating skin cancer, their clinical trials have been halted due to dose-dependent toxicity and poor water solubility. In this study, we present a rational approach to address these limitations and ensure colloidal stability of the nanoformulation over time by designing solid lipid-polymer hybrid nanoparticles (SLPH). Leveraging the biocompatible and cationic properties of polyaspartamides, we employed a new polyaspartamide derivative (P1) as a raw material for this class of nanostructures. Subsequently, we prepared SLPH through a one-step process involving hot-melt emulsification followed by ultrasonication. The physicochemical properties of the SLPH were thoroughly characterized using dynamic light scattering (DLS), ζ-potential analysis, nanoparticle tracking analysis (NTA), differential scanning calorimetry (DSC), Fourier-transform infrared spectroscopy (FT-IR), and transmission electron microscopy (TEM). The optimized formulation exhibited long-term stability over six months under low temperatures, maintaining a particle size around 200 nm, a polydispersity index (PdI) lower than 0.2, and a ζ-potential between +35-40 mV. Furthermore, we evaluated the cytotoxic effect of the SLPH against human cutaneous melanoma cells (SK-MEL-28) compared to human foreskin fibroblast cells (HFF-1). Encapsulation of glycoalkaloids into the nanoparticles (SLPH-GE) resulted in a two-fold greater selective cytotoxic profile for melanoma cells than glycoalkaloids-free (GE). The nanoparticles disrupted the stratum corneum barrier with a penetration depth of approximately 77 μm. These findings underscore the potential of the developed nanosystem as an effective glycoalkaloid carrier with suitable colloidal and biological properties for further studies in topical treatment strategies for cutaneous melanoma.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: